These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 24286456

  • 1. Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial.
    Neighbour H, Boulet LP, Lemiere C, Sehmi R, Leigh R, Sousa AR, Martin J, Dallow N, Gilbert J, Allen A, Hall D, Nair P.
    Clin Exp Allergy; 2014 Apr; 44(4):508-16. PubMed ID: 24286456
    [Abstract] [Full Text] [Related]

  • 2. Novel therapies targeting eosinophilic inflammation in asthma.
    Thomson NC.
    Clin Exp Allergy; 2014 Apr; 44(4):462-8. PubMed ID: 24666518
    [No Abstract] [Full Text] [Related]

  • 3. Vitamin D reduces eosinophilic airway inflammation in nonatopic asthma.
    de Groot JC, van Roon EN, Storm H, Veeger NJ, Zwinderman AH, Hiemstra PS, Bel EH, ten Brinke A.
    J Allergy Clin Immunol; 2015 Mar; 135(3):670-5.e3. PubMed ID: 25617224
    [Abstract] [Full Text] [Related]

  • 4. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses.
    Gauvreau GM, Boulet LP, Cockcroft DW, Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K, Duong M, Watson RM, Renzi PM, O'Byrne PM.
    Am J Respir Crit Care Med; 2008 May 01; 177(9):952-8. PubMed ID: 18244953
    [Abstract] [Full Text] [Related]

  • 5. Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
    Sehmi R, Smith SG, Kjarsgaard M, Radford K, Boulet LP, Lemiere C, Prazma CM, Ortega H, Martin JG, Nair P.
    Clin Exp Allergy; 2016 Jun 01; 46(6):793-802. PubMed ID: 26685004
    [Abstract] [Full Text] [Related]

  • 6. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
    Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM.
    N Engl J Med; 2009 Mar 05; 360(10):985-93. PubMed ID: 19264687
    [Abstract] [Full Text] [Related]

  • 7. Effects of oral prednisone on sputum eosinophils and cytokines in patients with severe refractory asthma.
    Dente FL, Bacci E, Bartoli ML, Cianchetti S, Costa F, Di Franco A, Malagrinò L, Vagaggini B, Paggiaro P.
    Ann Allergy Asthma Immunol; 2010 Jun 05; 104(6):464-70. PubMed ID: 20568377
    [Abstract] [Full Text] [Related]

  • 8. Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.
    Gonem S, Berair R, Singapuri A, Hartley R, Laurencin MFM, Bacher G, Holzhauer B, Bourne M, Mistry V, Pavord ID, Mansur AH, Wardlaw AJ, Siddiqui SH, Kay RA, Brightling CE.
    Lancet Respir Med; 2016 Sep 05; 4(9):699-707. PubMed ID: 27503237
    [Abstract] [Full Text] [Related]

  • 9. Eosinophil chemotaxis assay in nasal polyps by using a novel optical device EZ-TAXIScan: Role of CC-chemokine receptor 3.
    Saito H, Honda K, Asaka C, Ueki S, Ishikawa K.
    Allergol Int; 2016 Jul 05; 65(3):280-5. PubMed ID: 26874579
    [Abstract] [Full Text] [Related]

  • 10. Sputum CD34+IL-5Ralpha+ cells increase after allergen: evidence for in situ eosinophilopoiesis.
    Dorman SC, Efthimiadis A, Babirad I, Watson RM, Denburg JA, Hargreave FE, O'Byrne PM, Sehmi R.
    Am J Respir Crit Care Med; 2004 Mar 01; 169(5):573-7. PubMed ID: 14630618
    [Abstract] [Full Text] [Related]

  • 11. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.
    Pizzichini E, Leff JA, Reiss TF, Hendeles L, Boulet LP, Wei LX, Efthimiadis AE, Zhang J, Hargreave FE.
    Eur Respir J; 1999 Jul 01; 14(1):12-8. PubMed ID: 10489822
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Control of asthma symptoms and cellular markers of inflammation in induced sputum in children and adolescents with chronic asthma].
    Ciółkowski J, Stasiowska B, Mazurek H.
    Pol Merkur Lekarski; 2009 Mar 01; 26(153):178-83. PubMed ID: 19388528
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma.
    Stirling RG, van Rensen EL, Barnes PJ, Chung KF.
    Am J Respir Crit Care Med; 2001 Oct 15; 164(8 Pt 1):1403-9. PubMed ID: 11704586
    [Abstract] [Full Text] [Related]

  • 16. The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.
    Gauvreau GM, FitzGerald JM, Boulet LP, Watson RM, Hui L, Villineuve H, Scime TX, Schlatman AR, Obminski C, Kum J, Boehme S, Ly TW, Bacon KB, O'Byrne PM.
    Clin Exp Allergy; 2018 Apr 15; 48(4):445-451. PubMed ID: 29423947
    [Abstract] [Full Text] [Related]

  • 17. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
    Basyigit I, Yildiz F, Ozkara SK, Boyaci H, Ilgazli A.
    Mediators Inflamm; 2004 Aug 15; 13(4):285-91. PubMed ID: 15545060
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
    Xu J, Jiang F, Nayeri F, Zetterström O.
    Respir Med; 2007 Jul 15; 101(7):1447-54. PubMed ID: 17379492
    [Abstract] [Full Text] [Related]

  • 20. Chronic cough: eosinophilic bronchitis without asthma.
    Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE.
    Lancet; 1989 Jun 17; 1(8651):1346-8. PubMed ID: 2567371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.